Gate 322 Lofibra 67 mg (Lofibra 67 mg)

Generic Name: fenofibrate

Pill imprint Gate 322 Lofibra 67 mg has been identified as Lofibra 67 mg.

Lofibra is used in the treatment of hyperlipoproteinemia; hypertriglyceridemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 67 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for Gate 322 Lofibra 67 mg

Lofibra 67 mg Gate 322 Lofibra 67 mg
Lofibra 67 mg Gate 322 Lofibra 67 mg
Lofibra
Generic Name:
fenofibrate
Imprint:
Gate 322
Lofibra 67 mg
Strength:
67 mg
Color:
Pink
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Gate Pharmaceuticals
National Drug Code (NDC):
57844-0322
Inactive Ingredients:
croscarmellose sodium
crospovidone
lactose monohydrate
magnesium stearate
povidone k25
corn starch
sodium lauryl sulfate
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
titanium dioxide
gelatin

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)